Marijuana Breathalyzer T h l f L Technology for Law Enforcement

West Point Res. Inc

BLO - CSE

Disclaimer

• Information contained in this Presentation is the property of the Company. It is made available strictly for the purposes of providing background information. Neither the communication of this Presentation nor any part of its contents is to be taken as any form of commitment on the part of the Company to proceed with any transaction. This Presentation does not constitute, or form part of, any offer or invitation to sell or issue, or any solicitation p y p y , p , y , yof any offer to subscribe for or purchase any securities in the Company, nor shall it, or the fact of its communication, form the basis of, or be relied upon in connection with, or act as any inducement to enter into, any contract or commitment whatsoever with respect to such securities. The communication of this Presentation in or to persons in certain jurisdictions may be restricted by law and persons who may receive communication of this Presentation should inform themselves about, and observe, any such restrictions in advance of communication to them of this Presentation. Neither the CSE nor its Regulation Services Provider accepts responsibility for the adequacy or accuracy of this Presentation.

• The material contained in this presentation is provided solely for your general knowledge and is not intended to be a comprehensive review of all matters and developments concerning West Point or its affiliates. West Point has taken all reasonable care in producing the information contained in this presentation. This information may still contain technical or other inaccuracies, omissions, or typographical errors, for which West Point assumes no responsibility. West Point makes no representation or warranty regarding, and assumes no responsibility for, the use, validity, accuracy, completeness, p y p y g g, p y , , y, y, p ,reliability or currency of any claims, statements or information in this presentation.

• Statements in this presentation other than purely historical information, including statements relating to West Point’s future plans, objectives or expected results, constitute forward-looking statements. Forward-looking statements are based on numerous assumptions and are subject to the risks and uncertainties inherent in West Point’s business including risks inherent in mineral exploration and development As a result actual results may vary uncertainties inherent in West Point s business, including risks inherent in mineral exploration and development. As a result, actual results may vary materially from those described in the forward-looking statements. West Point disclaims any obligation to update any forward-looking statements.

• This presentation was prepared to assist interested parties in making their own assessment of West Point and its mineral properties, and does not purport to contain all of the information that a prospective investor may desire. In all cases, interested parties should conduct their own investigation and analysis

f th C it t d th i f ti id d i thi t ti Additi l i f ti b t th C i il bl it b it t of the Company, its assets and the information provided in this presentation. Additional information about the Company is available on its website at www.westpointresources.com and on SEDAR at www.sedar.com .Any and all statements, forecasts, projections and estimates contained in this presentation are based on management’s current knowledge and no representation or warranty is made as to their accuracy and/or reliability. This presentation does not constitute an offer to sell or a solicitation to buy any of the securities in the United States. The securities have not been and will not be registered under the United States Securities Act of 1933, as amended (“the U.S. Securities Act”) or any state securities law and may not be offered or sold in the United States or to U S Persons unless registered under the U S Securities Act and applicable state securities laws or an exemption from such in the United States or to U.S. Persons unless registered under the U.S. Securities Act and applicable state securities laws or an exemption from such registration is available.

Overview

West Point’s Cannabix Marijuana Breathalyzer Technology A first mover in developing a roadside handheld breathalyzer to detect

THC t f ij i b th p g y

THC component of marijuana in breath. West Point has an Exclusive North American Licence for patent pending

marijuana breathalyzer technology. Pioneering world experts on THC breath testing directly involved with Pioneering world experts on THC breath testing directly involved with

West Point. Targeting Law enforcement and workplace testing - Large market potential. Highly experienced management team Highly experienced management team. West Point is receiving extensive media coverage for its technology.

LISTED ON THE CSE BLOLISTED ON THE CSE: BLO

TeamKal Mahli, President, DirectorMr. Malhi is a Vancouver based entrepreneur and the founder of Cannabix Breathalyzer Inc. Mr. Malhi is a retired member of the Royal Canadian Mounted Police and is also President of BullRun Group, a private investment company specializing in early stage business development. Mr Malhi brings a wealth of

Dr. Bruce Goldberger, PhD, Senior AdvisorDr. Goldberger is a professor, and the director of toxicology for the Department of Pathology, Immunology and Laboratory Medicine in the College of Medicine at the University of Florida. Dr. Goldberger is the editor-in-chief of the Journal of Analytical Toxicology; the president of the American Board of Forensic p g y g p g

business and law enforcement experience to the management team and is cognizant of the issues of protecting individuals’ rights to privacy while maximizing public safety through law enforcement initiatives.

Dr. Raj Attariwala, MD, PhD., Chief Engineer D A i l i V b d d l b d ifi d R di l i d N l

Toxicology.

Jay Bala, CFA, DirectorMr. Bala currently works at a hedge fund. Most recently, Mr. Bala worked at a hedge fund with principal capital and a sub-advisor to a Sprott Fund. Previously h E it R h A l t t l di b ti I t t B k d Dr. Attariwala is a Vancouver based dual board certified Radiologist and Nuclear

Medicine physician certified in both Canada and the United States. He holds a doctorate in Biomedical Engineering from Northwestern University. Dr. Attariwala has worked closely with the breath testing technology developed by the Karolinska Institute and Dr. Olof Beck. He is the lead engineer on product design and patent applications for the WP THC Breathalyzer techology.

he was an Equity Research Analyst at a leading boutique Investment Bank and has also worked at the family office for one of Canada’s wealthiest families. Mr. Bala holds a Bachelor of Commerce degree from the University of Toronto and is a CFA charter holder.

Alex Kanayev, MBA, CGA, Directordesign and patent applications for the WP THC Breathalyzer techology.

Rav Mlait, MBA, CEO, DirectorMr. Mlait has extensive experience in managing and raising capital for public and private companies. Mr. Mlait has held executive positions with TSX, TSX Venture and CSE listed companies. Mr. Mlait was VP of Corporate development for

Alex Kanayev, MBA, CGA, DirectorMr. Kanayev is a Managing Partner at a venture capital and private equity firm, strategic advisor to several hedge funds and sits on the boards of several companies. Previously he has worked as Senior Vice President at a hedge fund with principal capital and a sub-advisor to a Sprott Fund. He used to work at Corporate Finance Division of Bank of Montreal as a Portfolio Manager. Alex p p p

knowledge-management and CRM software developer, Knexa Solutions Ltd., and financial portal, Stockhouse Media Corporation. Mlait holds an MBA from Royal Roads University, BA (Economics) from Simon Fraser University.

Bryan Loree BA, CMA, CFO, DirectorSi 2005 h h h ld i l f i i i

holds a MBA from Schulich School of Business at York University and is a Certified General Accountant.

Andrew Davies, MBA, AdvisorAndrew is a Chartered Mechanical Engineer and holds a BEng from the U i it f Li l d I t ti l E ti MBA f th U i it Since 2005 he has held numerous accounting roles for private companies in

various industries including, renewable energy, exploration, and construction. Mr. Loree has been the CFO of a TSX Venture Listed companies since since 2008.

University of Liverpool and an International Executive MBA from the University of Middlesex Business School, London. Andrew is the CEO of STI Pharmaceuticals Ltd., a leading cannabinoid research company based in London, England. He is also a sought after speaker at cannabinoid conferences globally.

Thomas Clarke, DirectorThomas Clarke, DirectorMr. Clarke served as a geologist for TSX Venture listed, BonTerra Resources from May 2010 to October, 2012. During his tenure, BonTerra defined an initial NI 43-101 compliant resource under his leadership. Thomas is a geologist holding a BSc. (Honours) and MSc in Geology from the University of the Witwatersrand as well as a BSc in Geography from the University of Lethbridge.

Marijuana Impaired Driving/ Drugged Driving

Marijuana impaired driving is second only to alcohol impaired driving accidents.

Drivers impaired by marijuana lose attentiveness, perception of time and speed and ability to draw on information obtained from past experiences.

Drivers impaired by marijuana have little fear of law enforcement as no tools exist to support criminal convictions.pp

'Drugged driving' is become a major issue, according to the US National Institute on Drug Abuse’s website. A 2012 National Survey on Drug Use and Health shows an estimated 10.3 million people aged 12 or older (or 3.9% of adolescents and adults) reported driving under the influence of illicit drugs during the year prior. Furthermore,

di t th N ti l Hi h T ffi S f t Ad i i t ti ’ 2007 N ti l R d id S th 16% according to the National Highway Traffic Safety Administration’s 2007 National Roadside Survey, more than 16% of weekend, night time drivers tested positive for illegal, prescription, or over-the-counter drugs. More than 11% tested positive for illicit drugs.

The NEED for a solution

Currently law enforcement has a strong tool for enforcing alcohol impaired driving- roadside alcohol breathalyzers.

Law Enforcement is facing challenges in enforcing law against drivers impaired by marijuana.

Current marijuana enforcement relies on officers “opinion” as to j pthe impairment by marijuana. This “opinion” does not have merit in court.

There is a growing NEED for the Cannabix Breathalyzer device.There is a growing NEED for the Cannabix Breathalyzer device.

Sampling of Media Attention for Cannabix

Impaired Driving

M 2014 Gl b d M il ti l DRUGED DRIVING May 2014 Globe and Mail article on DRUGED DRIVING Link: http://tinyurl.com/oavb5yg

“Th i l d id i l t f b th l f “There is also no roadside equivalent of a breathalyzer for drugs.”

“..in recent years police forces have spent hundreds of thousands of dollars to send officers to the United States for sophisticated drug recognition training. They leave qualified to visually detect impairment by seven classes of frequently used illegal drugs But their results have been scantused illegal drugs. But their results have been scant.

In 2012, just 1,126 drug impairment charges were laid against Canadian drivers compared with 60,000 charges for alcohol-impaired drivers. This is in part b h k f l f d d h l

p , g p pbecause the ranks of qualified drug recognition experts are thin – only 570 are on active duty across the country. And training new officers is expensive, ranging from $5,800 to $17,000 per officer in recent years.”

Impaired Driving

May 2014 National Public Radio – Denver, ColoradoLink: http://www.npr.org/2014/05/21/314279711/without-a-marijuana-breathalyzer-how-to-curb-

stoned drivingstoned-driving

“The state has added dozens of these specialists to plaw enforcement ranks. They're needed, since th i t t t f ij there is no easy way to test for marijuana impairment. "I wish we did, but no, we don't p , ,have a marijuana Breathalyzer," State Trooper Nicholas Hazlett says “Nicholas Hazlett says.

Impaired Driving

J l 2014 S i G tt W hi t St tJuly 2014 Sequim Gazette– Washington StateLink: http://www.sequimgazette.com/news/265620061.html

“ e er car a trooper stops he/she is looking …every car a trooper stops, he/she is looking for impairment each time and was procedure p pbefore the legalization of recreational cannabis. Despite there not being a breathalyzer test Despite there not being a breathalyzer test available for cannabis like there is for di ti i hi t f l h l i distinguishing amounts of alcohol in an individual’s system…”y

Investment Opportunity

• Law Enforcement is in urgent need of our product.

• Opportunities for research grants from public and private entities will be achievable.

• Only company that has patent applications on this technology.

• As marijuana becomes legalized in more jurisdictions and increasingly accepted by society, the need for our product will increase.

• The current alcohol breathalyzer market is worth is in excess of $3 The current alcohol breathalyzer market is worth is in excess of $3 BILLION DOLLARS in North America.

Investment Opportunity

• Public sentiment for investing in marijuana related businesses is at ll ti hi han all time high.

• Many investors will not endorse marijuana cultivation and sales y jbusiness based on ethics and stigma of being involved in marijuana.

• THC breathalyzer appeals to ALL investors who wish to take part in the opportunity presented by changes to marijuana regulations.pp y p y g j g

Cannabix Breathalyzer Device

• West Point is developing a hand held roadside breath collection device.

• Administered by law enforcement personnel after they have formulated grounds for belief that driver is impaired by marijuana.

• Test will be breath test only and can only collect evidence pertaining to usage of marijuana.

• Test results will be available within minutes of sample collection at roadside.

• Test kit will be utilized as evidence in prosecution of driving offences.

• The device will be similar to the current alcohol breathalyzer utilized in The device will be similar to the current alcohol breathalyzer utilized in screening alcohol impaired drivers. The court procedures to be followed will be similar to what is practiced with an alcohol breathalyzer.

Marijuana Legalization Uptrend

• Recent analysis on the American marijuana marketplace by ArcView Angel Investors forecast a 64-per-cent surge in the legal U.S. cannabis market to $2.34-billion in 2014. It also estimates that the five year national market could grow to $10 2 billion amid rising demand and potentially the five-year national market could grow to $10.2-billion amid rising demand and potentially new state markets.

• The five-year national market potential is $10.2 billion, which is more than a 700 percent increase above the current national market value Gains are projected to come in the form of increase above the current national market value. Gains are projected to come in the form of increased demand in existing state markets, as well as from new state markets coming online within a five-year horizon.

Ad lt i W hi t d C l d i j t d t dd $253 illi d $455 illi t • Adult use in Washington and Colorado is projected to add $253 million and $455 million to their respective markets in 2014. ArcView Market Research pre-dicts 14 states will adopt adult use regulations within five years. Those states are: Alaska, Oregon, Rhode Island, New Hampshire, Vermont, Maryland, Hawaii, Maine, Missouri, Massachusetts, Nevada, Arizona, California and Delaware California and Delaware.

• The retail legal marijuana price has been under downward pressure from increased competition between retailers and from falling production costs as cultivators improve their processes and take advantage of economies of scale With increased supply and lower prices processes and take advantage of economies of scale. With increased supply and lower prices and easier access means that marijuana will likely be more widely available for consumption and this leads to a significant challenge to law enforcement of those U.S. states with medical and legalized recreational use.

Technology Development Plan

Objectives Milestones ProjectedTi liTimeline

Develop a working prototype of the Cannabix

THC Breathalyzer

Cannabix THC Breathalyzer version

1.0

~Within 6 months

Trial testing of prototype with National Institute on Drug Abuse (NIDA) and

Completion of 3-4 month trial / research study with NIDA and

~10 months

g ( )the National Highway

Traffic Safety Administration (NHTSA)

yNHTSA.

Developing a commercial Cannabix THC

Breathalyzer for the marketplace

Commercialized product for licensing or

sale

~12-18 months

marketplace

Public Share Structure

Common Shares Shares Common Shares Shares Issued and Outstanding ~40M

Milestones and Timeline

P j t dB t

Beta 2.0Version of

THC Seek Listing on

U S OTCCloseFinancing& transaction

List onCSE

ProjectedBeta 1.0 Prototype Completion

THC Breathalyzer

U.S. OTC Market

U.S. and Canada

Tradeshows

Q2 Q3 Q4 Q1 Q2 2014

Q3 2014

Q4 2014

Q1 2015

Protoype Development

Start

Trial tests with NIDA and

NHTSAStart NHTSA

Note:The above timeline is general in nature and can change without notice.Note: e abo e t e e s ge e a atu e a d ca c a ge t out ot ce.

Contact Us

Corporate LawyersClark Wilson LLP885 West Georgia Street #900

West Point Rav Mlait, CEO

Mailing AddressWest Point Resources Inc. 

Transfer AgentTMX Equity Transfer & Trust Company

885 West Georgia Street #900, Vancouver, BC V6C 3H1

,604‐551‐7831rav@westpointresources.com

7934 Government RoadBurnaby, BC V5A 2E2

www.westpointresources.comWest Point  TMX Equity Transfer & Trust Company

650 West Georgia St, #2700Vancouver, BC V6E 4E6

Bryan Loree, CFO604‐808‐2225bryan.Loree@gmail.com

W t P i tWest Point Kal Malhi, President604‐805‐4602k.malhi@dccnet.com LISTED ON THE CSE: BLO LISTED ON THE CSE: BLO

Additional Disclaimer can be found at:http://wwwwestpointresources com/disclaimer htmlhttp://www.westpointresources.com/disclaimer.html